晶圓代工商格羅方德(GFS.US)獲高通(QCOM.US)額外42億美元訂單
全球第三大晶圓代工商格羅方德(GlobalFoundaries)(GFS.US)獲智能手機晶片商高通(Qualcomm)(QCOM.US)從紐約廠房增購42億美元晶片。總計至2028年,高通共承諾向格羅方德購買74億美元晶片。雙方早前達成32億美元採購協議,涉及5G訊號收發、無線網絡(Wi-Fi)、汽車及物聯網(IoT)。
格羅方德行政總裁Thomas Caulfield表示,公司擁有高通作為旗下紐約廠房的長期客戶,聯同聯邦及地方政府資金支持,有助公司擴大在美國的生產。
格羅方德去年於納斯達克交易所上市,集資26億美元,控股股東為阿聯酋阿布扎比主權基金Mubadala。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.